|
Active pharmaceutical ingredient found in anti-malarial medicine samples
|
Medicine labeled as
|
References
|
|---|
|
AS
|
CQ
|
DHA
|
HL
|
MQ
|
QN
|
TET
|
AL
|
SMP + PYR
|
DHA + PQP
|
|---|
|
2-Mercaptobenzothiazole
|
3
| | | | | | | | | |
[38]
|
|
Acetaminophen
|
17
| |
1
|
7
| | | | |
101*
| |
[5, 38, 40–42]
|
|
Artemisinin
|
4
| | |
4
| | | | | | |
[5, 38]
|
|
Aspirin
| |
1
| | | | | | | | |
[43]
|
|
Chloramphenicol
|
2
| | | | | | | | | |
[38]
|
|
Chloroquine
|
8
| | | | |
253*
| | | | |
[5, 34, 38, 41, 44–46]
|
|
Chlorpheniramine
| |
1
| | | | | | | | |
[47]
|
|
Dimethylfumarate
|
6
| | | | | | | | | |
[38]
|
|
Erucamide
|
1
| | | | | | | | | |
[38]
|
|
Erythromycin
|
7
| | | | | | | | | |
[38, 48]
|
|
Erythromycin and Paracetamol (acetaminophen)
|
8
| | | | | | | | | |
[49]
|
|
Sulphadoxine-pyrimethamine
| | | | | | | | |
100*
| |
[50]
|
|
Metamizol
|
5
| | | | | | | | | |
[38]
|
|
Pyrimethamine
|
8
| | | | | | |
2
| | |
[5, 38]
|
|
Pyrimethamine and Sulphadiazine
| | | | | | | |
1
| | |
[5]
|
|
Sildenafil
| | | | | | | | | |
4
|
[5]
|
|
Soya flour
| | | | | | |
100*
| | | |
[50]
|
|
Sulphadoxine
|
12
| | |
57600
| | | | | | |
[38, 39]
|
|
Sulphadoxine-pyrimethamine
|
30
| | | |
1
| | | | | |
[51, 52]
|
|
Sulphamethazine
| | | |
1
| | | | | | |
[53]
|
- 100* = Unknown number of samples. Missing number of samples from one set of samples of chloroquine, mefloquine, sulphadoxine-pyrimethamine and three set of samples of quinine. Anti-malarial medicines: AS: artesunate, CQ: chloroquine; DHA: dihydroartemisinin; HL: halofantrine; MQ: mefloquine; QN: quinine; TET: tetracycline; AL: artemether-lumefantrine; SMP + PYR: sulphamethoxypyrazine-pyrimethamine; DHA + PQP: dihydroartemisinin-piperaquine.
